SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 104 000 KRW -0.1% Market Closed
Market Cap: 8.1T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

SK Biopharmaceuticals Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SK Biopharmaceuticals Co Ltd
Revenue Peer Comparison

Comparables:
000100
008930
128940
S
000250
C
068760

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
SK Biopharmaceuticals Co Ltd
KRX:326030
Revenue
â‚©354.9B
CAGR 3-Years
139%
CAGR 5-Years
218%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Revenue
â‚©1.9T
CAGR 3-Years
-3%
CAGR 5-Years
5%
CAGR 10-Years
7%
Hanmi Science Co Ltd
KRX:008930
Revenue
â‚©1.3T
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
13%
Hanmi Pharm Co Ltd
KRX:128940
Revenue
â‚©1.6T
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
8%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Revenue
â‚©204.3B
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
6%
C
Celltrion Pharm Inc
KOSDAQ:068760
Revenue
â‚©402.7B
CAGR 3-Years
7%
CAGR 5-Years
19%
CAGR 10-Years
22%

See Also

What is SK Biopharmaceuticals Co Ltd's Revenue?
Revenue
354.9B KRW

Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's Revenue amounts to 354.9B KRW.

What is SK Biopharmaceuticals Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
218%

Over the last year, the Revenue growth was 44%. The average annual Revenue growth rates for SK Biopharmaceuticals Co Ltd have been 139% over the past three years , 218% over the past five years .

Back to Top